Work

Phase I trials of PS-341 (bortezomib, B) in combination with topotecan (T) in advanced solid tumors: A potential pharmacokinetic (PK) interaction.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.3108

Authors: Robert Morgan, Frances Valdes, Timothy W. Synold, Paul Henry Frankel, Christopher Ruel, Mary I. Carroll, Dean Lim, Mihaela C. Cristea, Marianna Koczywas, Lucille A. Leong, Vincent M. Chung, Karen L. Reckamp, Stephen Shibata, Jana Portnow, Warren Allen Chow, Przemyslaw Twardowski, Thehang H. Luu, George Somlo

Institutions: City Of Hope National Medical Center, City of Hope, University of Miami Health System

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598099537

Cites:

Cited by: 1

Related to: 10